Affiliation:
1. Oncology Department and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji
Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China
Abstract
Abstract:
Bile acids are well known to promote the digestion and absorption of fat, and at the
same time, they play an important role in lipid and glucose metabolism. More studies have found
that bile acids such as ursodeoxycholic acid also have anti-inflammatory and immune-regulating
effects. Bile acids have been extensively studied in biliary and intestinal tumors but less in pancreatic cancer. Patients with pancreatic cancer, especially pancreatic head cancer, are often accompanied by biliary obstruction and elevated bile acids caused by tumors. Elevated total bile acid levels in pancreatic cancer patients usually have a poor prognosis. There has been controversy over
whether elevated bile acids are harmful or beneficial to pancreatic cancer. Still, there is no doubt
that bile acids are important for the occurrence and development of pancreatic cancer. This article
summarizes the research on bile acid as a biomarker and regulation of the occurrence, development and chemoresistance of pancreatic cancer, hoping to provide some inspiration for future research.
Funder
National Natural Science Foundation of China
Scientific and Technological Innovation Project of Science and Technology Commission of Shanghai Municipality
Innovation Group Project of Shanghai Municipal Health Commission
Shanghai Municipal Commission of Health and Family Planning
Shanghai Municipal Education Commission—Gao Feng Clinical Medicine
Clinical Research Plan of SHDC
Shanghai Sailing Program
National Key R&D Program of China
CSCO Clinical Oncology Research Foundation
Innovative Research Team of High-Level Local Universities in Shanghai
Publisher
Bentham Science Publishers Ltd.